Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693120 · ClinicalTrials.gov registry record · NA
Evaluation of the Phased Radio Frequency Ablation System
A NA study, sponsored by Medtronic Cardiac Ablation Solutions.
- Terminated
- Registry status
- NA
- Development phase
- 199
- Enrollment target
NCT01693120 is a NA study that was terminated before completion, run by Medtronic Cardiac Ablation Solutions. The registered enrollment target is 199 participants.
The verdict
NCT01693120, a NA study, was terminated before completion, sponsored by Medtronic Cardiac Ablation Solutions.
- TERMINATED
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
Study Summary
VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation (AF) undergoing ablation with the Phased RF System.
Interventions
- DEVICE Medtronic Phased RF Ablation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-02-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693120
The ClinicalTrials.gov registry entry for NCT01693120 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Ablation Solutions, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medtronic Phased RF Ablation System is the first listed.
NCT01693120 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693120 about?
NCT01693120 is a clinical study titled "Evaluation of the Phased Radio Frequency Ablation System". VICTORY AF is an IDE, prospective global, multi-center, single arm, controlled, unblinded, investigational clinical study. The purpose of this clinical study is to evaluate the risk of procedure and/or device related strokes in subjects with persistent or long-standing persistent atrial fibrillation...
What is the current status of trial NCT01693120?
This trial is currently terminated. It is a NA study. The enrollment target is 199 participants. The study started on 2013-11. Estimated completion is 2017-02-07.
What interventions are being tested in trial NCT01693120?
The interventions under investigation include: Medtronic Phased RF Ablation System (DEVICE).
Who is sponsoring clinical trial NCT01693120?
This trial is sponsored by Medtronic Cardiac Ablation Solutions, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.